The PE Ratio as of December 2025 (TTM) for Coherus Oncology, Inc. (CHRS) is 2.24

According to Coherus Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 2.24. This represents a change of -462.96% compared to the average of -0.62 of the last 4 quarters.

Coherus Oncology, Inc. (CHRS) Historical PE Ratio (quarterly & annually)

How has CHRS PE Ratio performed in the past?

The mean historical PE Ratio of Coherus Oncology, Inc. over the last ten years is 0.34. The current 2.24 PE Ratio has changed 65.40% with respect to the historical average. Over the past ten years (40 quarters), CHRS's PE Ratio was at its highest in in the December 2020 quarter at 32.33. The PE Ratio was at its lowest in in the March 2019 quarter at -11.29.

Coherus Oncology, Inc. (CHRS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Coherus Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coherus Oncology, Inc. (CHRS) Average PE Ratio

How has CHRS PE Ratio performed in the past?

The current PE Ratio of Coherus Oncology, Inc. (CHRS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Coherus Oncology, Inc. (CHRS) PE Ratio vs. Peers

How is CHRS’s PE Ratio compared to its peers?

Coherus Oncology, Inc.’s PE Ratio is greater than OmniAb, Inc. (-3.55), greater than Invivyd, Inc. (-6.31), greater than SELLAS Life Sciences Group, Inc. (-6.53), greater than Codexis, Inc. (-2.50), greater than Avalo Therapeutics, Inc. (-2.52), less than Protalix BioTherapeutics, Inc. (25.72), greater than C4 Therapeutics, Inc. (-1.58), greater than Insight Molecular Diagnostics Inc. (-0.03), greater than Sangamo Therapeutics, Inc. (-2.15), greater than Protara Therapeutics, Inc. (-5.71),

Build a custom stock screener for Coherus Oncology, Inc. (CHRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coherus Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coherus Oncology, Inc. (CHRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coherus Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.